REDUCED HIPPOCAMPAL FIELD POTENTIALS DURING ADMINISTRATION OF FLUOROPYRIMIDINES INVITRO

被引:1
作者
BERGJOHNSEN, J
HEIER, MS
LANGMOEN, IA
机构
[1] ULLEVAL UNIV HOSP, DEPT NEUROSURG, N-0407 OSLO 4, NORWAY
[2] ULLEVAL UNIV HOSP, DEPT NEUROL, N-0407 OSLO 4, NORWAY
[3] NATL HOSP NORWAY, DEPT NEUROSURG, OSLO 1, NORWAY
来源
ACTA NEUROLOGICA SCANDINAVICA | 1987年 / 75卷 / 06期
关键词
D O I
10.1111/j.1600-0404.1987.tb05471.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:417 / 422
页数:6
相关论文
共 19 条
[1]   PHASE-II STUDY OF DOXIFLURIDINE IN ADVANCED COLORECTAL ADENOCARCINOMA [J].
ABELE, R ;
ALBERTO, P ;
KAPLAN, S ;
SIEGENTHALER, P ;
HOFMANN, V ;
RYSSEL, HJ ;
HARTMANN, D ;
HOLDENER, EE ;
CAVALLI, F .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) :750-754
[2]  
ABELE R, 1982, CANCER TREAT REP, V66, P1307
[3]  
ANDERSEN P, 1971, EXP BRAIN RES, V13, P208
[4]   FUNCTIONAL CHARACTERISTICS OF UNMYELINATED FIBERS IN HIPPOCAMPAL CORTEX [J].
ANDERSEN, P ;
SILFVENIUS, H ;
SUNDBERG, SH ;
SVEEN, O ;
WIGSTROM, H .
BRAIN RESEARCH, 1978, 144 (01) :11-18
[5]  
ANDERSEN P, 1966, EXP BRAIN RES, V1, P236
[6]  
BOURKE RS, 1973, CANCER RES, V33, P1735
[7]  
CLARKSON B, 1964, CLIN PHARMACOL THER, V5, P581
[8]  
GOTTLIEB JA, 1971, LANCET, V1, P138
[9]  
HARTMANN HR, 1982, CANCER RES, V42, P2412
[10]  
HEIDELBERGER C, 1965, PROGRESS NUCLEIC ACI, V4, P2